METHODS AND COMPOSITIONS FOR TREATING DISEASE Russian patent published in 2012 - IPC A61K48/00 A61P35/00 

Abstract RU 2468820 C2

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine, more specifically to oncology and concerns methods of treating or personalising therapy of cancer in a subject by specific removal of malignant cells from a cell population of peripheral blood, as well as a such method for specific removal of malignant cells from a cell population of peripheral blood intended for autologous transplantation. A cell population of peripheral blood containing malignant and non-malignant cells is taken from a subject and analysed for activity of at least one cancer marker in said cell population. It is followed by introducing into the cells a polynucleotide coding the selected marker and a polypeptide lethal for said malignant cells wherein expression of the lethal polypeptide is under direct or indirect control of a cancer marker promoter. The cells are exposed in selection conditions to produce cells containing said polynucleotide. The produced cells are treated in the conditions of expression induction of the lethal polypeptide which kills the cells expressing the cancer marker. Then the killed cells are separated from the living cells to be returned to the subject body.

EFFECT: presented new method for specific removal of malignant cells enables both cancer cell reinfusion into the patient's body in autologous transplantation, and makes it possible to personalise therapy of a malignant disease in the subject by structuring an individual therapeutic polynucleotide depending on subject's genotype.

45 cl, 8 dwg, 5 ex

Similar patents RU2468820C2

Title Year Author Number
CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION 2009
  • Bich Robert Patterson
  • Rid Tomas D.
RU2573912C2
MODIFIED DENDRITE CELLS AND THEIR USE IN TREATMENT OF MALIGNANT TUMOURS 2008
  • Brauler Dzh. Mark
  • Kumar Prasanna
  • Storkus Uolter Dzh.
  • Okada Khidekho
RU2484132C2
MODIFIED DENDRITIC CELLS AND THEIR APPLICATION FOR MALIGNANT TUMOURS TREATMENT 2013
  • Brauler Dzh. Mark
  • Kumar Prasanna
  • Storkus Uolter Dzh.
  • Okada Khidekho
RU2644210C2
NON-HUMAN ANIMALS WITH A GYRATE DEFICIENCY 2014
  • Lai Ka-Man Venus
  • Gong Guochun
  • Rinn John
  • Frendewey David
  • Valenzuela David M.
RU2721855C2
CHIMERIC ANTIGENIC RECEPTORS WITH MND-PROMOTER 2015
  • Morgan, Richard
  • Friedman, Kevin
  • Ryu, Byoung
RU2708311C2
EXPRESSION OF NEW CELL MARKS 2018
  • Shakh, Rutul
  • Emtejdzh, Piter
  • Yarlagadda, Ramya
RU2796334C2
MODIFIED DENDRITIC CELLS AND USE THEREOF IN TREATING MALIGNANT TUMOURS 2017
  • Brauler Dzh. Mark
  • Kumar Prasanna
  • Storkus Uolter Dzh.
  • Okada Khidekho
RU2711606C2
CHIMERIC ANTIGENIC RECEPTORS WITH MND PROMOTER 2015
  • Morgan, Richard
  • Friedman, Kevin
  • Ryu, Byoung
RU2799573C2
TARGETED MODIFICATION OF RAT GENOME 2014
  • Lee Jeffrey D.
  • Mujica Alexander O.
  • Auerbach Wojtek
  • Lai Ka-Man Venus
  • Valenzuela David M.
  • Yancopoulos George D.
RU2676708C2
METHOD OF PRODUCTION OF T-CELLS 2015
  • Fridman, Kevin
RU2813668C2

RU 2 468 820 C2

Authors

Rid Tomas D.

Bich Robert P.

Dates

2012-12-10Published

2007-07-26Filed